Press Releases

GOLETA, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, today announced that it has signed a letter of intent (LOI) for up to $30 million of proposed funding under the CHIPS and Science Act, which is administered by the U.S. Department of Commerce. The award will support Research & Development of Aeluma’s scalable, non-InP semiconductor manufacturing platform for photonics, an important technology for the U.S. economy and national security.  CHIPS funding is designed to advance semiconductor R&D, strengthen U

MALTA, N.Y., July 29, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ:GFS) today announced it has entered into a letter of intent (LOI) with the U.S. Department of Commerce to accelerate research and development of next-generation silicon photonics — the optical technology that moves data at the speed of light and underpins the AI and high-performance computing data centers driving the global economy. Under the LOI, the Department’s CHIPS Research and Development Office is expected to award GF $300 million to advance next-generation optical materials, wafer technologies and advanced packaging, reinforcing U.S. leadership in a technology essential to AI infrastructure. The award will acce

Completed the merger of Stellar Bancorp, Inc. into Prosperity Bancshares on July 1, 2026Second quarter net interest margin increased 29 basis points to 3.47% compared to second quarter 2025Second quarter net income of $168.6 million, and $162.7 million(1) excluding non-recurring items, an increase of 20.4% compared to second quarter 2025Second quarter earnings per share (diluted) of $1.67, or $1.62 excluding non-recurring items, an increase of 14.1% compared to second quarter 2025Noninterest-bearing deposits of $10.7 billion, representing 32.9% of total depositsAllowance for credit losses on loans and on off-balance sheet credit exposure of $420.5 million and allowance for credit losses on l

12% year-over-year revenue growth in Financial Services; $1.1 billion deployed on share repurchases Revenue of $5.5 billion increased 4.5% year-over-year or 4.1% in constant currency1Operating margin of 15.9% increased 30 basis points year-over-year; Adjusted Operating Margin1 of 16.0% increased 40 basis points year-over-yearGAAP EPS of $1.36 increased 3.8% year-over-year; Adjusted EPS1 of $1.37 increased 4.6% year-over-yearTrailing 12-month bookings of $29.1 billion increased 5% year-over-year2026 constant currency revenue growth guidance is revised to 4.0% to 5.5% year-over-year growth2026 Adjusted Operating Margin guidance is unchanged at 16.0% to 16.2%, year-over-year expansion of 20 to

2Q 2026 Diluted EPS of $1.322Q 2026 C&I adjusted diluted EPS of $1.31 2Q 2026 Managed receivables of $26.9 billion Declared quarterly dividend of $1.05 per shareNEW YORK, July 29, 2026 /PRNewswire/ -- OneMain Holdings, Inc. (NYSE:OMF), the leader in offering nonprime consumers responsible access to credit, today reported pretax income of $196 million and net income of $152 million for the second quarter of 2026, compared to $214 million and $167 million, respectively, in the prior year quarter. Earnings per diluted share were $1.32 in the second quarter of 2026, compared to $1.40 in the prior year quarter. On July 29, 2026, One

MARLBOROUGH, Mass., July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported basis and 7.0 percent on an operational1 and organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $907 million or $0.61 per share (EPS), compared to $797 million or $0.53 per share a year ago, and achieved adjusted3 EPS of $0.86 for the period, compared to $0.75 a year ago. "Our team delivered a solid quarter while continuing to navigate a

Company affirms guidance and outlooksNEW ORLEANS, July 29, 2026 /PRNewswire/ -- Entergy Corporation (NYSE:ETR) reported second quarter 2026 earnings per share of $1.03 on an as-reported and an adjusted (non-GAAP) basis. "At our investor day in June, we provided a comprehensive update on our differentiated growth story that starts with our customers," said Drew Marsh, Entergy Chair and Chief Executive Officer. "In the second quarter, we made steady progress across key customer, operational, regulatory, and financial areas. We remain solidly on track to achieve our objectives for 2026 and beyond."Business highlights included the

Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroomRevenue up 2.5% and diluted EPS accretion of 22.5% Q3-F2026 performance highlightsRevenue of $4.19 billion, up 2.5% year-over-year or 1.3% year-over-year in constant currency1;Earnings before income taxes of $633.9 million, up 14.9% year-over-year, for a margin1 of 15.1%;Adjusted earnings before interest and taxes1,2 of $681.7 million, up 2.3% year-over-year, for a margin1 of 16.3%;Net earnings of $465.2 million, up 13.8% year-over-year, for a margin1 of 11.1%, and diluted EPS of $2.23, up 22.5% year-over-year;Adjusted net earnings1,2 of $478.3 million, up 1.7% year-over-year, for a margin1 of 11.4%, and adjusted diluted EPS1,2 of $2.2

CLEVELAND, July 29, 2026 /PRNewswire/ -- NACCO Industries® (NYSE:NC) will release its 2026 Second Quarter financial results after the close of the market on Wednesday, August 5, 2026.In conjunction with this release, the Company will also host a conference call on Thursday, August 6, 2026 to discuss these results.        Conference Call:   Thursday, August 6, 2026Time:                   8:30 a.m. (Eastern Time)Telephone:           (888) 880-3330 (North America Toll Free), or(646) 357-8766 (International)Conference ID: 3241028(Call in at least five minutes before start time)For Replay Call:   (800) 770-2030 (Toll Free) or (609) 800-9909 (International)Conference Replay Entry Code: 3241028#Ava

DUBLIN, July 29, 2026 /PRNewswire/ -- Aon plc (NYSE:AON) today reported results for the three months ended June 30, 2026. Aon delivered another quarter of strong performance, including 2% total revenue growth, 5% organic revenue growth and operating margin expansion. We continue to execute our Aon United strategy, accelerated by the 3x3 Plan, to meet rising client demandOur free cash flow generation and robust balance sheet position support substantial financial flexibility. We returned $775 million to shareholders during the quarter through $600 million of share repurchases —  exceeding our full-year objective of at least $1 billion — and $175 million of dividendsWe are reaffirming 2026 gui

Banc of California, Inc. (NYSE:BANC): Quarter Results                   9% Loan Average Annualized Growth   12% Deposit Annualized Growth   $2.3 billion Securities Repositioning   $18.38 Book Value Per Share   $16.44 Tangible Book Value Per Share(1)   $(1.61) Loss Per Share Banc of California, Inc. (NYSE:BANC) ("Banc of California" or the "Company"), the parent company of wholly-owned subsidiary Banc of California (the "Bank"), today reported financial results for the second quarter ended June 30, 2026. During the second quarter, t

The long-term, pivotal, phase 3 ADVANCE OUTCOMES study of ralinepag in predominantly pre-treated patients with pulmonary arterial hypertension (PAH) met its primary endpoint and important secondary endpoints with statistical significance The results support the use of ralinepag as a once-daily oral prostacyclin receptor agonist upon approval by the U.S. Food and Drug Administration (FDA) Investigational ralinepag combines potent receptor binding affinity with continuous exposure to deliver long-term, durable efficacy, and clinically meaningful outcomes United Therapeutics Corporation (NASDAQ:UTHR), a public benefit corporation, today announced that The Lancet has published full result

Education Technology Services revenue up 15% YOY and operating income up 30% YOY Sophia Learning subscribers up 32% YOY and revenue up 27% YOY   U.S. Higher Education's healthcare portfolio total enrollment increased 11% YOY Strategic Education, Inc. (Strategic Education) (NASDAQ:STRA) today announced financial results for the period ended June 30, 2026. STRATEGIC EDUCATION CONSOLIDATED RESULTS Three Months Ended June 30 Revenue increased 4.9% to $337.3 million compared to $321.5 million for the same period in 2025, driven by strength within the Education Technology Services segment, an increase in U.S. Higher Education segment revenue per student, and favorable foreign currenc

Dynatrace (NYSE:DT), the leading AI-powered observability platform, today announced the appointment of Chandu Thota to its Board of Directors effective July 27, 2026. Mr. Thota brings more than 20 years of experience building and scaling technology platforms at the intersection of AI, cloud infrastructure, and enterprise software at leading technology companies, including Google and Microsoft. "Chandu is a visionary technology leader with deep expertise in AI, machine learning, and large-scale software platforms," said Rick McConnell, Dynatrace CEO and a member of the Board of Directors. "As every enterprise becomes an AI-powered business, Chandu’s experience leading AI product innovation

Smurfit Westrock plc (NYSE:SW) today announced the financial results for the second quarter ended June 30, 2026. Key Points: Net Sales of $8,031 million Net Income of $88 million, with a Net Income Margin of 1.1% Adjusted EBITDA1 of $1,140 million, with an Adjusted EBITDA Margin1 of 14.2% Net Cash Provided by Operating Activities of $765 million Quarterly dividend of $0.4523 per ordinary share Smurfit Westrock plc’s performance for the three months ended June 30, 2026 and 2025 (in millions, except margins and per share data): Three months ended June 30,   2026     2025 Net Sales $ 8,031   $ 7,940

Investment Will Expand Technology, Talent and Infrastructure as Marvell Celebrates 20 Years of Engineering Innovation in India Marvell Technology, Inc. (NASDAQ:MRVL), a leader in data infrastructure semiconductor solutions, today announced plans to invest $250 million in India over the next three years to expand its capabilities across technology, talent and infrastructure. The announcement coincides with a milestone event celebrating 20 years of innovation in India, highlighting the company’s contributions to global technology development, its continued investment in the region and its commitment to advancing India’s semiconductor ecosystem and engineering talent. As part of this inves

Compass Management will host a conference call at 8:00 am ET (1:00 pm UK) Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the second quarter and first half ended June 30, 2026, on August 5, 2026. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on August 5, 2026. A live webcast of the call will be available on the Compass Pathways website at: https://events.q4inc.com/attendee/246696001. The webcast will be archived for 30 days. About Compass Pathways We believe mental health patients deserve the possibilit

Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended June 30, 2026: Revenues of $678.2 millionBook-to-bill ratio of 1.06x, resulting in 1.12x book-to-bill for the trailing 12 monthsGAAP net loss of $(13.2) million, or $(0.14) per diluted shareAdjusted EBITDA of $58.7 millionAdjusted net income of $22.7 million, or $0.23 per diluted shareCash provided by operations of $28.9 million and free cash flow of $19.9 millionFull-year 2026 guidance increased to revenue of $2,620 million to $2,690 million and adjusted EBITDA of $205 million to $220 million DURHAM, N.C., July 29, 2026 (GL

Key Takeaways Continued strong demand with 24% year-over-year increase in contract awards and a 1.2x book-to-bill ratio for the quarter, positioning the company for continued successMiddle East resiliency with 10% organic revenue growth and a 1.1x book-to-bill ratioPortfolio-shaping initiatives implemented to prioritize profitable, sustainable growth and enhance long-term shareholder value Q2 2026 Financial Highlights Book-to-bill ratio of 1.2x, exceeded 1.0x in both segments and continued streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since 2019 IPO. Federal Solutions bookings increase 51% year-over-yearSignificant Q2 2026 wins underscore Parsons strategic position

Generally well-tolerated with no serious adverse events, bronchospasm or diarrhea; no study drug discontinuations 90% of patients had no [60%] or mild [30%] cough~450 total inhalations administered in patients with IPFGlobal Phase 2 INFLO-2 trial actively enrolling patientsConference call and webcast scheduled for July 29 at 4:30 p.m. ET DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD), a biopharmaceutical company focused on developing innovative, patient-centric therapies for chronic diseases, today announced positive topline results from INFLO-1, its Phase 1b randomized, double-blind, placebo-controlled study evaluating